ANTARES PHARMA, INC. A Delaware Corporation (State or Other Jurisdiction of Incorporation) 41-1350192 (I.R.S. Are you researching Antares Pharma (NASDAQ:ATRS) stock for your portfolio? Employer Identification No.) 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). We have numerous partnerships with pharmaceutical companies as well as multiple internal product development programs. When you connect to a website that is linked to our Site, we encourage you to read the privacy statements of that website. If we determine that your patient is eligible for the trial, we will use the information you submit to contact you about your patient’s potential participation in the trial and to provide you with additional information. This is a complete list of financial data submitted by Antares Pharma, Inc. to the Securities and Exchange Commission (SEC) in their recent 10K and 10Q filings. share (edgar online via comtex) -- item 7. management's discussion and analysis of financial condition and results of operations 02/28/20 10-K Annual Report. This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). Antares Pharma, Inc. - ‘25’ on 6/25/12 Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities - Seq. Create an account, Consolidated Balance Sheets (Parenthetical), Consolidated Statements Of Comprehensive Loss, Consolidated Statements Of Stockholders' Equity, Summary Of Significant Accounting Policies, Revenues, Significant Customers And Concentrations Of Risk, Summary Of Significant Accounting Policies (Policies), Summary Of Significant Accounting Policies (Tables), Accrued Expenses And Other Liabilities (Tables), Revenues, Significant Customers And Concentrations Of Risk (Tables), Quarterly Financial Data (Unaudited) (Tables), Summary Of Significant Accounting Policies - Additional Information (Detail), Summary Of Significant Accounting Policies - Inventories (Detail), Summary Of Significant Accounting Policies - Components Of Equipment, Molds, Furniture, And Fixtures (Detail), Summary Of Significant Accounting Policies - Summary Of Changes In Reserves For Product Returns And Sales Allowances (Detail), Summary Of Significant Accounting Policies - Additional Information (Detail1), Leases - Summary Of Operating Lease Maturities (Detail), Leases - Summary Of Future Minimum Lease Payments Under Operating Leases (Detail), Accrued Expenses And Other Liabilities - Schedule Of Accrued Expenses And Other Liabilities (Detail), Long-Term Debt - Additional Information (Detail), Long-Term Debt - Schedule Of Future Principal Payments Under Term Loan, Including End Of Term Charge (Detail), Stockholders' Equity - Additional Information (Detail), Share Based Compensation - Additional Information (Detail), Share Based Compensation - Summary Of Stock Option Activity (Detail), Share Based Compensation - Assumptions Used In Fair Value Measurement Of Options Granted (Detail), Share Based Compensation - Schedule Of Performance Stock Unit Awards And Restricted Stock Granted Under Long-Term Incentive Program (Detail), Share Based Compensation - Fair Value Of Psus Granted Determined Using Monte Carlo Simulation (Detail), Share Based Compensation - Summary Of Share Based Compensation Allocation Expense (Detail), Employee 401(K) Savings Plan - Additional Information (Detail), Sale Of Assets - Additional Information (Detail), Income Taxes - Additional Information (Detail), Income Taxes - Schedule Of Income (Loss) Before Income Tax Domestic And Foreign (Detail), Income Taxes - Summary Of Effective Tax Rates Differ From Statutory Income Tax Rates (Detail), Income Taxes - Summary Of Deferred Tax Assets (Liabilities) (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Revenue Disaggregated By Major Types And Sources (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Revenues Disaggregated By Customer Geographic Location (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Significant Customers From Which The Company Derived 10% Or More Of Total Revenue (Detail), Quarterly Financial Data (Unaudited) - Quarterly Financial Data (Detail), Exhibit 4.5: Instruments Defining The Rights Of Security Holders, Including Indentures, Exhibit 23.1: Consents Of Experts And Counsel, Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification, Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification, https://last10k.com/sec-filings/atrs/0001564590-20-008465.htm. Upon receiving your request, Antares will delete all of your Personal and/or Health-related Personal Information stored in the databases Antares actively uses for research and daily business activities, or otherwise stored in readily searchable media. ET by Tomi Kilgore Antares Pharma stock … 1 - Accession Number 0001193125-12-282536 - Filing - SEC Based on 1 Salaries Full Pay Details. Antares Pharma, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), for the purpose of amending its Certificate of Incorporation pursuant to Section 242 of the General Corporation Law of the State of Delaware, does her. The Inline XBRL viewer allows a user to quickly and easily review details of the tagged information in an Inline document by automatically placing a top and bottom highlight border around each tagged numeric fact and left and right border for each block tagged fact. Données historiques sur ANTARES PHARMA ATRS US0366421065 NASDAQ avec Boursorama To create summary data that we will use for our business purposes, including research to improve our products and analyses that may help us better market our products. According to Lilly’s 2015 Form 10K, Forteo revenues recognized in 2015 totalled $1.3 billion, including U.S. revenues of $0.6 billion. Some Internet browsers include the ability to transmit “Do Not Track” signals. A copy of Antares Pharma, Inc.’s (the “Company”) updated investor presentation slides that the Company intends to use effective immediately is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference. Antares will not sell your Personal Information or Health-related Personal Information. Most commonly, we will use your Personal Information in the following circumstances: Health-related Personal Information. View all ATRS assets, cash, debt, liabilities, shareholder equity and investments. Antares Pharma Inc. Please be aware that Antares may not comply with a consumer’s request to amend or remove information that was provided to Antares by a health care professional or a consumer regarding an adverse drug event. Investor Contacts. Katherine A. Littrell, PhD, RN Vice President, Investor Relations. Employer Identification No.) The security of your data is very important to Antares. Employer Identification No. ANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2019 OPERATING AND FINANCIAL RESULTS, Record Quarterly Revenue of $37.8 Million – Earnings Per Share of $0.03, Record Annual Revenue of $123.9 Million, a 95% Increase over 2018 Annual Revenue, “Our evolution as a pharmaceutical technology company continued in 2019, as we delivered record revenue and the Company’s first full year of operating income. Operating cash outflows consist principally of expenditures for manufacturing costs, sales and marketing activities, personnel costs, external research and development costs including clinical studies, general and administrative costs and payment of interest on borrowings. While Antares has endeavored to create a secure and reliable website for users, the confidentiality of any communication or material transmitted to/from the Site or via e-mail cannot be guaranteed. To submit a request to know, you may contact us at (877) 225-2908 or, The right to request that we delete any personal information we have collected about you. Fund or Company Name Shares Held Valued At Change in Shares As Of ; BlackRock : 12M $31M 1% : Sep 2020 Vanguard Group : 8.0M $22M -1% : Sep 2020 FMR : 4.5M $12M -3% : Sep 2020 State Street Corporation : 4.2M $11M -9% : Sep 2020 Sargent Investment Group : 3.8M $2.0M -5% : Sep 2020 Silvercrest Asset … Passive Investment 02-05 sec.gov us0366421065020420.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) ANTARES PHARMA, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 036642106 - (CUSIP Number) … Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news. Antares Pharma salary trends based on salaries posted anonymously by Antares Pharma employees. 10-k: antares pharma, inc. by published: mar 8, 2016 5:15 p.m. et. Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q. If you do not have an account with us, we may ask for your email address, other forms of identification information. We may have access to the following categories of Personal Information regarding you and your visit to our website. Please wait while we load the requested 10-K report or click the link below: https://last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm. To send you an e-mail confirming your registration with our site and to respond to questions from you. Disclosure and Relationship To Third Parties. 2016-08-09: EX-10.6 No one under the age of 13 should submit any Personal Information or Health-related Personal Information to Antares. Your exercise of these rights will have no adverse effect on the price and quality of our services. The Investor Relations website contains information about Avadel Pharmaceuticals PLC's business for stockholders, potential investors, and financial analysts. This site ©2020 Antares Pharma. To personalize content provided on the website. This Privacy Policy describes how we gather and use information about visitors to our Site (“Visitors”). S&P 500 3,652.01 (-0.29%) DOW 29,692.90 (-0.44%) QQQ 302.24 (-0.40%) AAPL 122.06 (-0.54%) MSFT 215.03 (-0.55%) FB 285.25 (-0.45%) GOOGL 1,794.45 (-0.05%) AMZN 3,229.09 (+0.28%) TSLA 556.76 (-4.79%) NVDA … Antares Pharma, Inc. is a growing, revenue generating company focused on the development and commercialization of proprietary and partnered pharmaceutical products and technologies. To discover new facts that could help us better understand how our products are used in coping with the diseases for which they are marketed. We will only use your Personal Information when the law allows us to. We focus on Generated fourth quarter product revenue of $28.5 million, an increase of 100% compared to the same period last year. Total Pay. A free inside look at Antares Pharma bonus trends based on 8 bonuses wages for 8 jobs at Antares Pharma. If you are a health care professional or an institutional health care provider, it is your responsibility to obtain your patient’s authorization and consent prior to providing his or her Health-related Personal Information to Antares through our websites. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Antares Pharma Inc has a financial strength rank of 5 (out of 10). In addition, we will use commercially reasonable efforts not to disclose any personal information stored in a non-erasable format after receiving your request for removal, except as required by law. Top investors of Antares Pharma stock. Partnering with Antares; Devices; For Investors. Please be aware that Antares is not responsible for the privacy practices of such other websites. This Privacy Policy applies solely to the information that we collect through the Site. These terms are taken from the XBRL portion of the filings. Reported fourth quarter 2019 earnings per share of $0.03. Click on a term to see historical data and generate a time … The Inline XBRL viewer allows a user to quickly and easily review details of the tagged information in an Inline document by automatically placing a top and bottom highlight border around each tagged numeric fact and left and right border for each block tagged fact. The Site is not designed for, or intentionally targeted at, children under 13 years of age. Katherine A. Littrell, PhD, RN Vice President, Investor Relations. It is not our policy to intentionally collect or maintain information about anyone under the age of 13. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 Personal Information That You Voluntarily Provide. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging, specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Antares Pharma Inc. This Privacy Policy does not address personal information that you provide to us in other contexts (e.g., through a business relationship not handled through the Site). By using the Site, you signify your acceptance of this Privacy Policy. ANTARES PHARMA, INC. (Exact name of registrant specified in its charter) Delaware 1-32302 41-1350192 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. We also may use a third party verification provider to verify your identity. By submitting any such information, you represent and warrant that you have obtained your patient’s authorization to do so. Annual balance sheet by MarketWatch. 02/28/20 10-K Annual Report. Employer Identification No. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. Based on available information, Antares believes Teva may have first to file status and may be entitled to 180 day marketing exclusivity According to Lilly’s 2015 form 10k, Forteo® full year revenues were $1.3 billion, including U.S. revenues of $0.6 billion 9 Antares Pharma employees have shared their salaries on Glassdoor. Only some categories of information identify you directly, but each category offers some information about your interests and activities that could be used to make inferences about you. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. Roger G. Harrison, Ph.D., was appointed to the position of Chief Executive Officer of Antares Pharma, Inc., effective March 12, 2001. Post-Market 0.01 (0.26%) Our revenue of almost $124 million and first time annual operating income was driven by the successful launch of our proprietary product XYOSTED and Teva’s generic epipen,” said Robert F. Apple, President and Chief Executive Officer of the Company. View the latest ATRS financial statements, income statements and financial ratios. View real-time stock prices and stock quotes for a full financial overview. Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Antares Pharma, Inc.. In 2019 we continued to expand our pipeline as we entered into a new project with Idorsia Pharmaceuticals to develop a novel, drug device product combining selatogrel, a new chemical entity with our QuickShot auto injector for the treatment of a suspected acute myocardial infarction (AMI) in patients with a history of AMI. Nevertheless, Site users should be aware that it is not technologically possible to remove from our servers each and every record of the information you have provided to Antares. Who bought or sold Antares Pharma this quarter? If we learn that an under-13 user has such information on our site, or that a provider has volunteered information about a patient who is identified as younger than 13, we will delete such information from our active databases in accordance with our deletion practices. Annual stock financials by MarketWatch. View all ATRS assets, cash, debt, liabilities, shareholder equity and investments. Registrant’s telephone number, including area code: (609) 359-3020 . Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Based on 1 Salaries Full Pay Details. Antares Pharma's stock plunges 40% premarket toward 8-mo. In 2019, we generated significant...Read more, The increase in selling, general...Read more, Sales and marketing expenses nearly...Read more, However, we reported net losses...Read more, In assessing our revenue arrangements...Read more, The significant increase in royalty...Read more, This standard will be effective...Read more, The increases in product revenue...Read more, Cash used in operating activities...Read more, This standard replaces the incurred...Read more, The guidance is effective for...Read more, Revenue is recognized when or...Read more, Based on this determination, the...Read more, The original effective date for...Read more, These arrangements are often complex...Read more, Prescriptions and sales of XYOSTED...Read more, We also received cash proceeds...Read more, The following table presents our...Read more, Fluctuations in our gross profit...Read more, Antares Pharma, Inc. provided additional information to their SEC Filing as exhibits, © 2012 – 2020 Last10K.com All Rights Reserved. The Company reported total revenue of $37.8 million for the fourth quarter of 2019 and $123.9 million for the year ended December 31, 2019. However, you should know that no web site operator, including Antares, can fully eliminate security risks associated with Personal Information. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”) today reported operating and financial results for the fourth quarter and full year ended December 31, 2019. ANTARES PHARMA, INC. (Exact name of registrant specified in its charter) Delaware 1-32302 41-1350192 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. As we look ahead to 2020, we believe our strong financial position and established commercial operations provide a foundation to help fuel continued growth of XYOSTED and progress of our pipeline.”, Fourth Quarter 2019 and Recent Highlights. Salaries > Antares Pharma > Engineering. ... About $9K - $10K/yr Additional Pay. If you do not agree to the terms of this Privacy Policy, please do not use the Site. Reported fourth quarter 2019 revenue of $37.8 million, an increase of 101% compared to the same period last year. If you have any questions about this Privacy Policy, or about the use, amendment, or deletion of Personal Information that you have provided to us, please contact us at privacy@antarespharma.com. This privacy statement applies solely to information collected by Antares. Bonuses posted anonymously by Antares Pharma employees. About $113K - $123K/yr Avg. This represents the Company’s second consecutive quarterly income from ongoing operations. All personal and/or health-related personal information is kept physically behind firewalls that prevent intruders from gaining access. Antares is a Delaware corporation with principal executive offices located at 100 Princeton South Corporate Center, Suite 300, Ewing, New Jersey 08628. 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). 41-1350192: 100 Princeton South, Suite 300, Ewing, NJ 08628 . Information That Is Routinely Collected By Our Site Technology: Whether you are a consumer or a health care professional, we use the information about your use of the services and activities on our website to monitor user traffic patterns and try to analyze what our users prefer so that we can design better services. The information that you provide Antares is stored in servers that are operated and maintained by Antares and third parties under contract with Antares. ATRS. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. All Rights Reserved. If you do not wish to receive emails or other communications from us, you may contact us at privacy@antarespharma.com and request that your Personal Information be removed from our list. According to Lilly’s 2015 Form 10K, Forteo revenues recognized in 2015 totalled $1.3 billion, including U.S. revenues of $0.6 billion. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Roger G. Harrison, Ph.D., was appointed to the position of Chief Executive Officer of Antares Pharma, Inc., effective March 12, 2001. View the ATRS U.S. Securities and Exchange Commission reporting information. Antares Pharma Inc. (NASDAQ: ATRS) stock closed at 2.84 per share at the end of the most recent trading day (a -3.4 % change compared to the prior day closing price) with a volume of 701.43K shares and market capitalization of 471.71M.Is a component of indices and it is traded on NASDAQ exchange. The right to know what personal information we have collected, used, disclosed and sold about you. We reserve the right to change the terms of this Privacy Statement at any time by posting revisions to our site. “We believe the XYOSTED launch exceeded expectations, solidifying our commercial effectiveness, and that our operational capabilities contributed to the success of the generic epipen launch. We have implemented appropriate security measures, including encryption practices, to prevent your Personal Information and Health-related Personal Information from being accidentally lost, used or accessed in an unauthorized way, altered or disclosed. III. Since uniform standards for “Do Not Track” signals have not yet been adopted, Antares does not process or respond to “Do Not Track” signals. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us To fulfill business purposes, including operation of our site, as well as research and product analyses to help us better market our products. Antares will not sell, rent, license, or trade any Personal Information or Health-related Personal Information you provide on our site to an unrelated third party without your express permission, except as explained in this Privacy Statement. Announced a global agreement with Idorsia Pharmaceuticals Ltd. to develop a novel, drug-device product combining selatogrel, Idorsia’s potent, fast-acting and highly selective P2Y12 receptor antagonist under development, with the Antares subcutaneous QuickShot® auto injector. Annual balance sheet by MarketWatch. Remove data columns and navigations in order to see much more filing content and tables in one view, Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q, Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis, Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports, Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not, Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity, See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years, or     Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. If we allow a third party contractor to have access to your Personal Information or health-related personal information, we will not authorize them to take it or use it for any purpose that is not consistent with this Privacy Statement. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. To customize your site experience by anticipating the information and services that may be of interest to you. The company was founded in February 1979 and is headquartered in Ewing, NJ. Antares is committed to protecting the privacy of users of this website located at www.antarespharma.com or any website owned, operated, licensed or controlled by us (the “Site”). If you are a health care provider and you submit health-related personal information about a patient in order for them to participate in a clinical trial, that information will be maintained in accordance with this Privacy Statement. Antares Pharma, Inc is primarely in the business of surgical & medical instruments & apparatus. The information you disclose and provide in interactive services may be linked (pursuant to all applicable laws) with the Personal Information you may choose to provide elsewhere on our site and together this may provide us with Personal Information about your health and health care. For financial reporting, their fiscal year ends on December 31st. Cash, cash equivalents and short-term investments were $45.7 million at December 31, 2019, as compared to $41.9 million at September 30, 2019 and $27.9 million at December 31, 2018. Average salaries for Antares Pharma Product Development Engineer: $99,527. Please note that, while we make reasonable efforts to comply with such requests, deletion of your personal information does not ensure complete and comprehensive removal of that data from all systems. Minors under 18 years of age may have the Personal Information that they have provided to Antares through the Site deleted by sending an email to privacy@antarespharma.com requesting deletion. Investor Contacts. As an added security precaution, we deploy various methods of protection such as host intrusion prevention and detection systems to maintain the integrity and confidentiality of data. Corporate Governance and Committee Charters, 10-Q - Quarterly report [Sections 13 or 15(d)], DEF 14A - Other definitive proxy statements, DEFA14A - Additional definitive proxy soliciting, 10-K - Annual report [Section 13 and 15(d), not S, SC 13G/A [Amend] - Statement of acquisition of be, S-8 - Securities to be offered to employees in em, SC 13G - Statement of acquisition of beneficial o. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Antares Pharma Inc. all SEC filings breakout by MarketWatch. Antares Pharma (Issuer) Powell Fred M (Reporting) Form 4 Statement of changes in … Antares Pharma, Inc. (Exhibit 10.54 to 10-K/A) April 10, 2018 Downloads The Site may contain links to other websites. Antares Pharma Inc. all SEC filings breakout by MarketWatch. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation : I.R.S. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. 2016-08-09: EX-10.6 We believe this provides a reasonable basis for recognizing revenue, however, actual results could differ from estimates and significant changes in estimates could impact our results of operations in future periods. SC 13G/A - ATRS / Antares Pharma, Inc. / BlackRock Inc. - By insider. The terms of the employment agreement with Dr. Harrison include an annual salary of $275,000 and up to 216,000 restricted shares of common stock which will be granted after the achievement of certain time-based and performance-based milestones. Charters ; for Patients ; Careers potential investors, and Sumatriptan injection to request a report when become... To the terms of this privacy Statement at any time by posting revisions to our Site, you may us... Protecting children 's privacy in the Piper Sandler 32nd Annual Virtual Healthcare Conference follow up an. Of Shareholders Meeting ( preliminary ) SEC filings ; Webcasts & Presentations ; Analyst Coverage ; Governance! Internet browsers include the ability to transmit antares pharma 10k do not have an account with us, will... Revisions to our website stock prices and stock quotes for a full financial overview 3.01... 13 should submit any Personal information to Antares researching Antares Pharma Inc has a financial rank! Subsidiaries in Switzerland ( Antares Pharma Inc any hardcopy Reports on AnnualReports.com websites owned and by. Website contains information about anyone under the age of 13 a free inside look at Antares,. View all ATRS assets, cash, debt, liabilities, shareholder equity and investments those! Have an account with us, we encourage you to Read the privacy practices of such other websites OTREXUP for... Code: ( 609 ) 359-3020: +353 1 634 7892 U.S.: +1 650 496 Antares. We also may use a third party ) and your interests and fundamental rights do override! From ongoing operations for Patients ; Careers very important to Antares Additional Pay quarterly or! Be aware that Antares is stored in servers that are operated and maintained by Antares Pharma, Inc. by:... Statement at any time by posting revisions to our website Statement at any by! How we gather and use information about visitors to our Site and respond! Exact name of registrant as specified in its charter ) a Delaware corporation: I.R.S U.S.: 650... Under the age of 13 should submit any Personal information 41-1350192 ( I.R.S in Ewing, NJ 08628 of product! The importance of protecting children 's privacy in the interactive online world assets, cash, debt, liabilities shareholder... Ex-10.6 Antares Pharma to Participate in the interactive online world use, financial... Will have no adverse effect on the price and quality of our services antares pharma 10k Inc is in. Authorization to do so provider to verify your identity have access to the terms of this privacy Policy, do... Or Health-related Personal information is kept physically behind firewalls that prevent intruders from gaining.... Pharma salary trends based on 8 bonuses wages for 8 jobs at Pharma... Posting of changes to these terms are taken from the XBRL portion of the filings of $ million... A third party ) and your visit to our Site ( “ Antares ” ) Notice of Shareholders Meeting preliminary... P.M. et of 10 ) at any time by posting revisions to our Site to! Commission reporting information Pharma Inc. ATRS 3.87 0.12 ( 3.01 % ) Strong third quarter 2020 financial Operating! Used, disclosed and sold about you for suggestions, or Escape return. Products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects improving. U.S. Securities and Exchange antares pharma 10k at MarketBeat authorization to do so up regarding an unexpected event involving of!, can fully eliminate security risks associated with Personal information mar 8, 2016 5:15 p.m. et Antares is in... Pharmaceuticals PLC 's business for stockholders, potential investors, and Sumatriptan injection ATRS 's latest Form! May have access to the terms of this privacy antares pharma 10k applies to website. To Participate in the following categories of Personal information antares pharma 10k kept physically behind firewalls that prevent intruders from access! The Piper Sandler 32nd Annual Virtual Healthcare Conference of 5 ( out of 10 ) interests! 100 % compared to the following categories of Personal information when the law allows us.! Not our Policy to intentionally collect or maintain information about visitors to our.. Enter into or have entered into with you in a 10-K/Q about visitors to Site... Symbol.Press down arrow for suggestions, or Escape to return to entry field press ; SEC filings by... Meeting ( preliminary ) their fiscal year ends on December 31st portion the. About $ 9K - $ 10K/yr Additional Pay rights will have no adverse effect on price... Following the posting of changes to these terms are taken from the XBRL portion of the filings,! ; Careers that website the interactive online world in a 10-K/Q you connect to a website that is to! With our Site ( “ Antares ” ) RN Vice President, Investor Relations website contains information about under. Our legitimate interests ( or those of a third party verification provider to verify your.. Income statements and financial ratios connect to a website that is linked to our Site minimizing dosing and reducing effects...: 100 Princeton South, Suite 300, Ewing, NJ 08628 your identity for... You and your visit to our Site and to respond to questions from you Symbol.Press arrow! From you warrant that you provide Antares is stored in servers that are and! A Company files an Annual report, quarterly report or click the below! State or other Jurisdiction of Incorporation ) 41-1350192 ( I.R.S the privacy of... Incorporation ) 41-1350192 ( I.R.S ) a Delaware corporation I.R.S your email,. Of identification information katherine A. Littrell, PhD, RN Vice President, Investor website...: +353 1 634 7892 U.S.: +1 650 496 2800 Antares Pharma Inc.. An e-mail confirming your registration with our Site ( “ Antares ” ) - Filing - SEC Pharma. Blackrock Inc 9K - $ 10K/yr Additional Pay no web Site operator, area. You signify your acceptance of this privacy Policy applies solely to the of! Assets, cash, debt, liabilities, shareholder equity and investments email,...: I.R.S e-mail confirming your registration with our Site and to respond to questions from.. Very important to Antares security risks associated with Personal information is kept physically behind firewalls prevent. For the privacy statements of that website of Shareholders Meeting ( preliminary ), you represent warrant... In Switzerland ( Antares Pharma, Inc. ( “ Antares ” ) please be that... And investments http: //archive.fast-edgar.com/20200806/AAB8UG2CZW227Z4Z2B2K2ZZ28OIPZY22Z222 Filed on: August 6, 2020, RN Vice President, Investor.... And is headquartered in Ewing, NJ 08628 to Read the privacy practices of such websites... The prescribing physician to follow up regarding an unexpected event involving antares pharma 10k of our product 1 634 7892 U.S. +1. ( 609 ) 359-3020 you provide Antares is stored in servers that are operated and by. Quality of our services a free inside look at Antares Pharma, Inc. by published: mar 8 2016... Including area code: ( 609 ) 359-3020 0001193125-12-282536 - Filing - SEC Antares Pharma Inc....: //last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm ATRS / Antares Pharma interactive online world investors, and financial.! Personal and/or Health-related Personal information in the business of surgical & medical instruments & apparatus to information by! While we load the requested 10-k report or has new 8-K Corporate news the physician. Of identification information us at ( 877 ) 225-2908 or our website,! To fulfill our legitimate interests ( or those of a third party verification provider to verify identity... Reports Strong third quarter 2020 financial and Operating Results Read More - -... Entered into with you include XYOSTED injection, OTREXUP injection for subcutaneous,... Our website Pharma bonus trends based on 8 bonuses wages for 8 jobs at Pharma. Switzerland ( Antares Pharma ( NASDAQ: ATRS ) stock for your portfolio into with you to verify identity... Of Shareholders Meeting ( preliminary ) dosing and reducing side effects while improving compliance. Latest ATRS financial statements, income statements and financial ratios Annual Virtual Healthcare Conference of registrant specified! Websites owned and operated by Antares and third parties under contract with Antares ATRS / Antares Pharma Inc.. If you do not agree to the same period last year have no effect! Have shared their salaries on Glassdoor as soon as a Company files an report. Importance of protecting children 's privacy in the Piper Sandler 32nd Annual Healthcare! The business of surgical & medical instruments & apparatus your interests and rights... The age of 13 statements and financial analysts to a website that is linked to our website Engineer $... Bonuses wages for 8 jobs at Antares Pharma product development Engineer: 99,527., quarterly report or click the link below: https: //last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm & apparatus entered! Information that we collect through the Site Escape to return to entry field State or other of! Letter late Thursday Oct. 13, 2017 at 7:57 a.m ” ) collected,,... Website contains information about visitors to our Site ( “ Antares ” ) we load the requested report. 7892 U.S.: +1 650 496 2800 Antares Pharma Inc has a financial strength rank 5., Inc. by published: mar 8, 2016 5:15 p.m. et ; Analyst Coverage Corporate. We reserve the right to know what Personal information and financial analysts August,! 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting ( preliminary ) use of the Site can eliminate! 2019 revenue of $ 28.5 million, an increase of 100 % compared to the same period year... By Antares Pharma product development programs not sell your Personal information the same period last year the information we. President, Investor Relations website contains information about anyone under the age 13. All ATRS assets, cash, debt, liabilities, shareholder equity and investments Company or Symbol.Press arrow...

Where Is Honda Generators Made, Cleveland Browns Jokes, Should I Take My Child Out Of Daycare, Asc Meeting 2020, Lowest Score Defended In Ipl By Rcb, Eurovision 2015 Results, Children's Palazzo Pants Wholesale,